-
(a) On and after January 1, 2017, to establish uniformity in the submission of prior authorization forms for prescription drugs, a utilization review entity shall utilize only a single standardized prior authorization form for obtaining approval in written or electronic form for prescription drug benefits.
-
(b) A utilization review entity may make the form required under subsection (a) of this section accessible through multiple computer operating systems.
-
(c) The form required under subsection (a) of this section shall:
-
(1) Not exceed two (2) pages; and
-
(2) Be designed to be submitted electronically from a prescribing provider to a utilization review entity.
-
-
(d) This section does not prohibit prior authorization by verbal means without a form.
-
(e) If a utilization review entity fails to use or accept the form developed under this section or fails to respond as soon as reasonably possible, but no later than seventy-two (72) hours, after receipt of a completed prior authorization request using the form developed under this section, the prior authorization request is deemed authorized or approved.
-
(f)
-
(1) On and after January 1, 2017, each utilization review entity shall submit its prior authorization form to the State Insurance Department to be kept on file.
-
(2) A copy of a subsequent replacement or modification of a utilization review entity’s prior authorization form shall be filed with the department within fifteen (15) days before the form is used or before implementation of the replacement or modification.
-
